Filter
2703
Text search:
drugs
act
Featured
Recommendations
244
New Publications
799
Language
Document type
No document type
1704
Studies & Reports
357
Guidelines
298
Manuals
127
Strategic & Response Plan
97
Training Material
57
Fact sheets
26
Situation Updates
12
Infographics
8
Resource Platforms
7
Brochures
6
Online Courses
1
Countries / Regions
India
216
Kenya
128
Global
93
South Africa
90
Nigeria
81
Uganda
79
Sierra Leone
75
Zambia
65
Ghana
59
Tanzania
58
Malawi
55
Nepal
52
Liberia
51
Ethiopia
48
Western and Central Europe
47
Bangladesh
41
Africa
36
Myanmar / Burma
33
Rwanda
32
Philippines
31
Namibia
27
Latin America and the Carribbean
26
Asia
24
Zimbabwe
23
South–East Asia Region
21
Lesotho
17
Ukraine
16
Eastern Europe
15
South Sudan
14
Syria
14
Botswana
13
Burkina Faso
12
Senegal
12
Cambodia
12
Indonesia
12
Eswatini/ Swaziland
12
Mozambique
11
Congo, Democratic Republic of
9
Pakistan
9
Germany
9
Cameroon
8
Afghanistan
8
Russia
8
Eastern Europe and Central Asia
7
Venezuela
7
Thailand
6
East and Southern Africa
6
Albania
6
Vietnam
6
Guinea
4
USA
4
Sri Lanka
4
Yemen
4
Laos
4
Georgia
4
Somalia
3
Lebanon
3
China
3
Benin
3
Brazil
3
Libya
3
Bhutan
3
Mali
2
Haiti
2
Iraq
2
Papua New Guinea
2
Sudan
2
Central African Republic
2
Argentina
2
North Macedonia
2
Middle East and North Africa
2
Western Pacific Region
2
Southern Africa
2
Timor Leste/ East Timor
2
Moldova
2
North America
2
United Kingdom
2
Morocco
1
Saudi Arabia
1
Jordan
1
Chad
1
Gambia
1
Ireland
1
Singapore
1
Peru
1
Switzerland
1
Burundi
1
Greece
1
Angola
1
Madagascar
1
Mexico
1
West and Central Africa
1
Paraguay
1
Fiji
1
Poland
1
Palestine
1
Armenia
1
Canada
1
Tajikistan
1
Bulgaria
1
Estonia
1
Lithuania
1
Iran
1
Australia
1
Gabon
1
Turkmenistan
1
Maldives
1
Mauritius
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
1251
Clinical Guidelines
163
Public Health
126
Women & Child Health
126
Key Resources
88
Capacity Building
69
Pharmacy & Technologies
18
Toolboxes
HIV
299
Mental Health
233
TB
132
AMR
110
COVID-19
86
Pharmacy
84
Caregiver
76
NTDs
63
Malaria
54
Refugee
47
Conflict
44
NCDs
39
Ebola & Marburg
36
Planetary Health
33
Disability
32
Global Health Education
32
Health Financing Toolbox
23
Rapid Response
22
Natural Hazards
15
Social Ethics
12
Specific Hazards
10
Cholera
8
Polio
8
Zika
6
2.0 Rapid Response
6
South Sudan
2
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa
...
Known avoidable environmental risks to health cause at least 12.6 million deaths every year, and account for about one quarter of the global burden of disease (2016 data) (1). Air pollution alone causes about 7 million
deaths a year, placing it among the top global risks to health (2). Global envir
...
The community-BFCI (c-BFCI) manual has been developed to facilitate training of CHVs and stakeholders providing nutrition sensitive services at community level. The manual covers a wide range of topics: basic nutrition, exclusive breastfeeding, complementary feeding, Breast Milk Substitutes
...
This handbook is an adaptation from the WHO Clinical Handbook Health care for women subjected to intimate partner violence or sexual violence developed by the World Health Organization (WHO), UN Women and United Nations Population Fund. The handbook draws on the work from professionals who are dedic
...
Drawing on the World Health Organization’s package of NCD best buys, the report demonstrates how these evidence-based measures can help countries reduce premature deaths, strengthen health systems, and advance progress towards the Sustainable Development Goals. It provides policymakers, donors, ad
...
The findings of the report are both urgent and devastating. At the current rate of progress, by 2040 we would still have 1.9 million new HIV infections and 990,000 AIDS-related deaths in children. But if funding for HIV prevention and treatment continues to fall as current trends suggest, the world
...
World malaria report 2025
recommended
Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backbone of malaria treatments after failures of chloroquine and sulfadoxine-pyrimethamine – has now b
...
World malaria report 2025. Excecutive Summary
recommended
Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backbone of malaria treatments after failures of chloroquine and sulfadoxine-pyrimethamine – has now b
...
In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These guidelines outline a public health response to HIV, viral hepatitis and sexually transmitted infections (STIs) for 5 key populations (men who have s
...
Continuum of HIV services refers to a comprehensive package of HIV prevention, diagnostic, treatment, care and support services provided for people at risk of infection or living with HIV and their families. This revised edition of the guidelines for use of ARV and opportunistic infection
(OI)
...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus
...
The ACT Consortium was an international research collaboration dedicated to evaluating the effectiveness, safety and implementation of artemisinin-based combination therapies (ACTs) for treating malaria. Operating across multiple countries in Africa
...
Vaccine Management in Indonesia
Accessed November, 2017
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
